U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ACHIRAL
Molecular Formula C6H7N5O
Molecular Weight 165.1527
Optical Activity NONE
Defined Stereocenters 0 / 0
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of 6-METHOXYGUANINE

SMILES

COC1=C2N=CNC2=NC(N)=N1

InChI

InChIKey=BXJHWYVXLGLDMZ-UHFFFAOYSA-N
InChI=1S/C6H7N5O/c1-12-5-3-4(9-2-8-3)10-6(7)11-5/h2H,1H3,(H3,7,8,9,10,11)

HIDE SMILES / InChI

Approval Year

PubMed

PubMed

TitleDatePubMed
Tamoxifen accelerates proteasomal degradation of O6-methylguanine DNA methyltransferase in human cancer cells.
2007-11-15
Correlation between promoter hypermethylation of GSTP1 and response to chemotherapy in diffuse large B cell lymphoma.
2007-08
Methylation of O6-methylguanine DNA methyltransferase and loss of heterozygosity on 19q and/or 17p are overlapping features of secondary glioblastomas with prolonged survival.
2007-05-01
Silencing of O6-methylguanine DNA methyltransferase in the absence of promoter hypermethylation in hepatocellular carcinomas from Australia and South Africa.
2007-04
Dose response relationship in anti-stress gene regulatory networks.
2007-03-02
Low frequency of promoter methylation of O6-methylguanine DNA methyltransferase and hMLH1 in ulcerative colitis-associated tumors: comparison with sporadic colonic tumors.
2007-03
A distinct epigenetic signature at targets of a leukemia protein.
2007-02-01
Sulfolobus solfataricus DNA polymerase Dpo4 is partially inhibited by "wobble" pairing between O6-methylguanine and cytosine, but accurate bypass is preferred.
2007-01-12
Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.
2007-01-11
Analysis of gene expression and chemoresistance of CD133+ cancer stem cells in glioblastoma.
2006-12-02
Polymorphisms in O6-methylguanine DNA methyltransferase and endometrial cancer risk.
2006-11
Correlations between O6-methylguanine DNA methyltransferase promoter methylation status, 1p and 19q deletions, and response to temozolomide in anaplastic and recurrent oligodendroglioma: a prospective GICNO study.
2006-10-10
DNA damage-induced cell death by apoptosis.
2006-09
A pilot study of dose-intensified procarbazine, CCNU, vincristine for poor prognosis brain tumors utilizing fibronectin-assisted, retroviral-mediated modification of CD34+ peripheral blood cells with O6-methylguanine DNA methyltransferase.
2006-09
Mismatch repair-dependent iterative excision at irreparable O6-methylguanine lesions in human nuclear extracts.
2006-08-11
DNA methyltransferases messenger RNA expression and aberrant methylation of CpG islands in non-small-cell lung cancer: association and prognostic value.
2006-07
Polymorphisms in O6-methylguanine DNA methyltransferase and breast cancer risk.
2006-07
Role of temozolomide in pediatric brain tumors.
2006-07
High frequency and strong prognostic relevance of O6-methylguanine DNA methyltransferase silencing in diffuse large B-cell lymphomas from the Middle East.
2006-06
ATR kinase activation mediated by MutSalpha and MutLalpha in response to cytotoxic O6-methylguanine adducts.
2006-05-19
The syntheses and properties of tricyclic pyrrolo[2,3-d]pyrimidine analogues of S6-methylthioguanine and O6-methylguanine.
2006-05-07
In vivo effects of myeloablative alkylator therapy on survival and differentiation of MGMTP140K-transduced human G-CSF-mobilized peripheral blood cells.
2006-05
Progressive low-grade oligodendrogliomas: response to temozolomide and correlation between genetic profile and O6-methylguanine DNA methyltransferase protein expression.
2006-04-15
Simultaneous quantitation of 7-methyl- and O6-methylguanine adducts in DNA by liquid chromatography-positive electrospray tandem mass spectrometry.
2006-04-03
Inhibitory effects of caraway (Carum carvi L. ) and its component on N-methyl-N'-nitro-N-nitrosoguanidine-induced mutagenicity.
2006-02
Mutually exclusive promoter hypermethylation patterns of hMLH1 and O6-methylguanine DNA methyltransferase in colorectal cancer.
2006-02
O6-methylguanine DNA methyltransferase and p53 status predict temozolomide sensitivity in human malignant glioma cells.
2006-02
DNA repair enzyme, O6-methylguanine DNA methyltransferase, modulates cytotoxicity of camptothecin-derived topoisomerase I inhibitors.
2006-02
Effect of chemotherapy-induced DNA repair on oncolytic herpes simplex viral replication.
2006-01-04
Promoter hypermethylation of DNA repair gene MGMT in laryngeal squamous cell carcinoma.
2006
[Comparison of geno- and cytotoxicity of methylnitrosourea on MMR-proficient and MMR-deficient human tumor cell lines].
2006
Predictive utility of circulating methylated DNA in serum of melanoma patients receiving biochemotherapy.
2005-12-20
Epigenetics of cervical cancer. An overview and therapeutic perspectives.
2005-10-25
Exon 3 polymorphisms and haplotypes of O6-methylguanine-DNA methyltransferase and risk of bladder cancer in southern China: a case-control analysis.
2005-09-08
Epigenetic silencing of the MGMT gene in cancer.
2005-08
Nelarabine: a nucleoside analog with efficacy in T-cell and other leukemias.
2005-06
Loss of DNA minor groove interactions by exonuclease-deficient Klenow polymerase inhibits O6-methylguanine and abasic site translesion synthesis.
2005-05-10
[Effect of beta-carotene supplementation on DNA oxidative and alkylation damage in rats].
2005-05
Mitochondrial targeting of human O6-methylguanine DNA methyltransferase protects against cell killing by chemotherapeutic alkylating agents.
2005-04-15
Electrochemical detection of lesions in DNA.
2005-03-17
Genetic pathways to glioblastomas.
2005-03
Lack of EGF receptor contributes to drug sensitivity of human germline cells.
2005-01-31
Inhibition by allyl sulfides and crushed garlic of O6-methylguanine formation in liver DNA of dimethylnitrosamine-treated rats.
2005
Intra- and intercellular variations in the repair efficiency of O6-methylguanine, and their contribution to kinetic complexity.
2004-12-21
Dexamethasone protected human glioblastoma U87MG cells from temozolomide induced apoptosis by maintaining Bax:Bcl-2 ratio and preventing proteolytic activities.
2004-12-08
The combi-targeting concept: dissection of the binary mechanism of action of the combi-triazene SMA41 in vitro and antitumor activity in vivo.
2004-12
Therapeutic impact of methoxyamine: blocking repair of abasic sites in the base excision repair pathway.
2004-06
Guanine 6-O-methylation pattern within the dioxin responsive element of the CYP1A1 enhancer shows two critical guanines for AhR/ARNT binding.
2004-03
[Promoter hypermethylation of DNA repair gene O6-methylguanine DNA methyltransferase in laryngeal squamous cell carcinoma].
2004-03
BRAF/K-ras mutation, microsatellite instability, and promoter hypermethylation of hMLH1/MGMT in human gastric carcinomas.
2004
Name Type Language
6-METHOXYGUANINE
Common Name English
NSC-37364
Preferred Name English
PURINE, 2-AMINO-6-METHOXY-
Systematic Name English
NELARABINE METABOLITE (METHYLGUANINE)
Common Name English
O-(6)-METHYLGUANINE
Common Name English
METHYLGUANINE, O(6)-
Common Name English
6-METHOXY-1H-PURINE-2-AMINE
Systematic Name English
Code System Code Type Description
NSC
37364
Created by admin on Mon Mar 31 19:23:31 GMT 2025 , Edited by admin on Mon Mar 31 19:23:31 GMT 2025
PRIMARY
CAS
20535-83-5
Created by admin on Mon Mar 31 19:23:31 GMT 2025 , Edited by admin on Mon Mar 31 19:23:31 GMT 2025
PRIMARY
FDA UNII
9B710FV2AE
Created by admin on Mon Mar 31 19:23:31 GMT 2025 , Edited by admin on Mon Mar 31 19:23:31 GMT 2025
PRIMARY
PUBCHEM
65275
Created by admin on Mon Mar 31 19:23:31 GMT 2025 , Edited by admin on Mon Mar 31 19:23:31 GMT 2025
PRIMARY
WIKIPEDIA
6-O-Methylguanine
Created by admin on Mon Mar 31 19:23:31 GMT 2025 , Edited by admin on Mon Mar 31 19:23:31 GMT 2025
PRIMARY
CHEBI
20689
Created by admin on Mon Mar 31 19:23:31 GMT 2025 , Edited by admin on Mon Mar 31 19:23:31 GMT 2025
PRIMARY
EPA CompTox
DTXSID9049405
Created by admin on Mon Mar 31 19:23:31 GMT 2025 , Edited by admin on Mon Mar 31 19:23:31 GMT 2025
PRIMARY